Compound details
Betanidin
| Compound ID | CDAMM01457 |
|---|---|
| Common name | Betanidin | IUPAC name | 1-[2-(2,6-dicarboxy-2,3-dihydro-1H-pyridin-4-ylidene)ethylidene]-5,6-dihydroxy-2,3-dihydroindol-1-ium-2-carboxylate |
| Molecular formula | C18H16N2O8 |
| Retention time | 8.15 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 389.097 | Theoretical mz | 389.098 |
| Error | 2.25 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.1787 |
| Inchi key | XHJKHSXHWJCBLX-UHFFFAOYNA-N |
|---|---|
| Smiles | O=C(O)C1=CC(=CC=[N+]2C3=CC(O)=C(O)C=C3CC2C(=O)[O-])CC(N1)C(=O)O |
| Superclass | Organoheterocyclic compounds |
| Class | Indoles and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P12821 | ACE | Angiotensin-converting enzyme | T98311 | SwissTargetPrediction |
| P00915 | CA1 | Carbonic anhydrase I | T13201 | SwissTargetPrediction |
| P00918 | CA2 | Carbonic anhydrase II | T20401 | SwissTargetPrediction |
| P22748 | CA4 | Carbonic anhydrase IV | T53378 | SwissTargetPrediction |
| P39086 | GRIK1 | Glutamate receptor ionotropic kainate 1 | T73495 | SwissTargetPrediction |
| Q13002 | GRIK2 | Glutamate receptor ionotropic kainate 2 | T58178 | SwissTargetPrediction |
| Q14832 | GRM3 | Metabotropic glutamate receptor 3 | T02719 | SwissTargetPrediction |
| O15303 | GRM6 | Metabotropic glutamate receptor 6 | T55956 | SwissTargetPrediction |
| Q14416 | GRM2 | Metabotropic glutamate receptor 2 | T62820 | SwissTargetPrediction |
| Q07075 | ENPEP | Aminopeptidase A | T31956 | SwissTargetPrediction |
| Q04760 | GLO1 | Glyoxalase I | T88285 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T98311 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P12821 | ACE |
| T98311 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P12821 | ACE |
| T13201 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00915 | CA1 |
| T13201 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00915 | CA1 |
| T20401 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P00918 | CA2 |
| T20401 | DI0137 | Essential hypertension | [ICD-11: BA00] | P00918 | CA2 |
| T20401 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00918 | CA2 |
| T20401 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P00918 | CA2 |
| T20401 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P00918 | CA2 |
| T20401 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00918 | CA2 |
| T53378 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P22748 | CA4 |
| T53378 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22748 | CA4 |
| T53378 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P22748 | CA4 |
| T73495 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P39086 | GRIK1 |
| T73495 | DI0396 | Substance abuse | [ICD-11: 6C40] | P39086 | GRIK1 |
| T02719 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q14832 | GRM3 |
| T62820 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | Q14416 | GRM2 |
| T62820 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | Q14416 | GRM2 |
| T62820 | DI0116 | Dengue fever | [ICD-11: 1D2Z] | Q14416 | GRM2 |
| T62820 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | Q14416 | GRM2 |
| T62820 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | Q14416 | GRM2 |
| T62820 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | Q14416 | GRM2 |
| T62820 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q14416 | GRM2 |
| T62820 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | Q14416 | GRM2 |
| T62820 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q14416 | GRM2 |
| T31956 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | Q07075 | ENPEP |
| T88285 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | Q04760 | GLO1 |